A Study of TQ05105 Tablets in Subjects With Myeloproliferative Neoplasms

NCT04339400 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

50

Enrollment

INDUSTRY

Sponsor class

Conditions

Myeloproliferative Neoplasms

Interventions

DRUG: TQ05105

Sponsor

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.